OSUR logo

OraSure Technologies (OSUR) Stock

Profile

Sector:

Healthcare

Country:

United States

IPO:

17 November 1986

Indexes:

Not included

Description:

OraSure Technologies, Inc. is an American company founded in 1986, headquartered in Bethlehem, Pennsylvania, USA. The company is involved in the development, manufacturing, promotion, and sale of oral fluid diagnostic devices and specimen collection devices using its technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests used for different types of specimens. The company operates in two segments: OSUR and DNAG. The OSUR segment includes the development, manufacturing, and sale of diagnostic products, specimen collection devices, and medical devices. The DNAG segment, or molecular diagnostics segment, primarily consists of the development, manufacturing, and sale of devices for collecting oral fluid specimens.

Key Details

Price

$3.84

Annual Revenue

$405.47 M(+4.64% YoY)

Annual EPS

$0.72(+400.00% YoY)

PE Ratio

25.60(+138.36% YoY)

Beta

1.01

Events Calendar

Earnings

Next earnings date:

Feb 27, 2025

Recent quarterly earnings:

Nov 06, 2024

Recent annual earnings:

Feb 27, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Apr 08, 1987

Analyst ratings

Recent major analysts updates

07 Aug '24 Evercore ISI Group
In-Line
02 July '24 Evercore ISI Group
In-Line
13 May '24 JP Morgan
Neutral
04 Apr '24 Evercore ISI Group
In-Line
29 Feb '24 JP Morgan
Neutral
11 Dec '23 Citigroup
Buy
08 Nov '23 JP Morgan
Neutral
17 July '23 Stephens & Co.
Equal-Weight
11 May '22 Citigroup
Buy
24 Feb '22 Citigroup
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Institutional Ownership

OraSure to Participate in Upcoming Investor Conference
OraSure to Participate in Upcoming Investor Conference
OraSure to Participate in Upcoming Investor Conference
OSUR
globenewswire.com18 November 2024

BETHLEHEM, Pa., Nov. 18, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) announced today that the company is scheduled to participate in the following investor conference:

OraSure Technologies, Inc. (OSUR) Q3 2024 Earnings Call Transcript
OraSure Technologies, Inc. (OSUR) Q3 2024 Earnings Call Transcript
OraSure Technologies, Inc. (OSUR) Q3 2024 Earnings Call Transcript
OSUR
seekingalpha.com06 November 2024

OraSure Technologies, Inc. (OSUR) Q3 2024 Earnings Call Transcript

OraSure Technologies (OSUR) Reports Q3 Loss, Tops Revenue Estimates
OraSure Technologies (OSUR) Reports Q3 Loss, Tops Revenue Estimates
OraSure Technologies (OSUR) Reports Q3 Loss, Tops Revenue Estimates
OSUR
zacks.com06 November 2024

OraSure Technologies (OSUR) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to earnings of $0.27 per share a year ago.

OraSure: An NCAV Diamond In The COVID Rough
OraSure: An NCAV Diamond In The COVID Rough
OraSure: An NCAV Diamond In The COVID Rough
OSUR
seekingalpha.com04 November 2024

OraSure Technologies Inc. is a health and wellness company specializing in "easy to use" diagnostic and specimen collection products. OraSure has a strong balance sheet and is trading below its net current asset value (NCAV). At the same time, OraSure has a stable operational history with consistent normalized cash flow margins.

Neuberger Berman Group LLC Expands Stake in OraSure Technologies Inc
Neuberger Berman Group LLC Expands Stake in OraSure Technologies Inc
Neuberger Berman Group LLC Expands Stake in OraSure Technologies Inc
OSUR
gurufocus.com04 October 2024

On September 30, 2024, Neuberger Berman Group LLC, a prominent investment firm, made a significant addition to its investment portfolio by acquiring 3,927,692 shares of OraSure Technologies Inc (OSUR, Financial). This transaction, executed at a price of $4.27 per share, marks a notable increase in the firm's holdings in the medical devices sector.

OraSure Technologies (OSUR) Tops Q2 Earnings and Revenue Estimates
OraSure Technologies (OSUR) Tops Q2 Earnings and Revenue Estimates
OraSure Technologies (OSUR) Tops Q2 Earnings and Revenue Estimates
OSUR
zacks.com06 August 2024

OraSure Technologies (OSUR) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of $0.03 per share. This compares to loss of $0.07 per share a year ago.

OraSure to Announce Second Quarter 2024 Financial Results and Host Earnings Call on August 6th
OraSure to Announce Second Quarter 2024 Financial Results and Host Earnings Call on August 6th
OraSure to Announce Second Quarter 2024 Financial Results and Host Earnings Call on August 6th
OSUR
globenewswire.com22 July 2024

BETHLEHEM, Pa., July 22, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering second quarter 2024 financial results and certain business developments for 5 p.m. ET on August 6, 2024.

OraSure Technologies, Inc. (OSUR) Q4 2023 Earnings Call Transcript
OraSure Technologies, Inc. (OSUR) Q4 2023 Earnings Call Transcript
OraSure Technologies, Inc. (OSUR) Q4 2023 Earnings Call Transcript
OSUR
Seeking Alpha27 February 2024

OraSure Technologies, Inc. (OSUR) Q4 2023 Earnings Call Transcript

OraSure to Participate in Upcoming Investor Conferences
OraSure to Participate in Upcoming Investor Conferences
OraSure to Participate in Upcoming Investor Conferences
OSUR
GlobeNewsWire13 November 2023

BETHLEHEM, Pa., Nov. 13, 2023 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced the company is scheduled to participate in the following investor conferences:

OraSure Technologies (OSUR) Tops Q3 Earnings and Revenue Estimates
OraSure Technologies (OSUR) Tops Q3 Earnings and Revenue Estimates
OraSure Technologies (OSUR) Tops Q3 Earnings and Revenue Estimates
OSUR
Zacks Investment Research07 November 2023

OraSure Technologies (OSUR) came out with quarterly earnings of $0.27 per share, beating the Zacks Consensus Estimate of $0.07 per share. This compares to earnings of $0.07 per share a year ago.

  • 1(current)
  • 2
  • 1(current)
  • 2

FAQ

  • What is the primary business of OraSure Technologies?
  • What is the ticker symbol for OraSure Technologies?
  • Does OraSure Technologies pay dividends?
  • What sector is OraSure Technologies in?
  • What industry is OraSure Technologies in?
  • What country is OraSure Technologies based in?
  • When did OraSure Technologies go public?
  • Is OraSure Technologies in the S&P 500?
  • Is OraSure Technologies in the NASDAQ 100?
  • Is OraSure Technologies in the Dow Jones?
  • When was OraSure Technologies's last earnings report?
  • When does OraSure Technologies report earnings?
  • Should I buy OraSure Technologies stock now?

What is the primary business of OraSure Technologies?

OraSure Technologies, Inc. is an American company founded in 1986, headquartered in Bethlehem, Pennsylvania, USA. The company is involved in the development, manufacturing, promotion, and sale of oral fluid diagnostic devices and specimen collection devices using its technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests used for different types of specimens. The company operates in two segments: OSUR and DNAG. The OSUR segment includes the development, manufacturing, and sale of diagnostic products, specimen collection devices, and medical devices. The DNAG segment, or molecular diagnostics segment, primarily consists of the development, manufacturing, and sale of devices for collecting oral fluid specimens.

What is the ticker symbol for OraSure Technologies?

The ticker symbol for OraSure Technologies is NASDAQ:OSUR

Does OraSure Technologies pay dividends?

No, OraSure Technologies does not pay dividends

What sector is OraSure Technologies in?

OraSure Technologies is in the Healthcare sector

What industry is OraSure Technologies in?

OraSure Technologies is in the Medical Instruments & Supplies industry

What country is OraSure Technologies based in?

OraSure Technologies is headquartered in United States

When did OraSure Technologies go public?

OraSure Technologies's initial public offering (IPO) was on 17 November 1986

Is OraSure Technologies in the S&P 500?

No, OraSure Technologies is not included in the S&P 500 index

Is OraSure Technologies in the NASDAQ 100?

No, OraSure Technologies is not included in the NASDAQ 100 index

Is OraSure Technologies in the Dow Jones?

No, OraSure Technologies is not included in the Dow Jones index

When was OraSure Technologies's last earnings report?

OraSure Technologies's most recent earnings report was on 6 November 2024

When does OraSure Technologies report earnings?

The next expected earnings date for OraSure Technologies is 27 February 2025

Should I buy OraSure Technologies stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions